Anthem Biosciences Limited, a prominent innovation-driven Contract Research, Development, and Manufacturing Organization (CRDMO), is poised to launch its Initial Public Offering (IPO). The company offers fully integrated services, spanning drug discovery, development, and manufacturing. It caters to a global clientele, including innovative biotech firms and large pharmaceutical companies.
Table of Contents
About The Company
Anthem Biosciences excels in producing specialized fermentation-based Active Pharmaceutical Ingredients (APIs) such as probiotics, enzymes, peptides, and biosimilars. As of September 30, 2024, the company was actively involved in 196 projects, including discovery, early-phase, late-phase, and commercial manufacturing for 10 molecules. Anthem serves a broad customer base across 44 countries and holds multiple patents in India and overseas. The company’s strengths lie in its comprehensive service offerings across the drug life cycle, an innovation-focused approach, and strong customer relationships.
Crucial Shariah Status
Regarding the Shariah compliance status, Anthem Biosciences Ltd.’s ruling is currently pending.
Reason: We came across some doubtful products. We’ve contacted the company regarding them and are currently waiting for their response. We will await their reply until the last day before making a final decision on the ruling for this business. We will update the Shariah status as soon as we have conclusive information.
Anthem Biosciences IPO: Key Details
The Initial Public Offering of Anthem Biosciences Ltd. is structured as a Bookbuilding Issue. The IPO is set to open on Monday, July 14, 2025, and will close on Wednesday, July 16, 2025.
| IPO Details | Information |
| IPO Date | July 14, 2025 to July 16, 2025 |
| Face Value | ₹2 per share |
| Issue Price Band | ₹540 to ₹570 per share |
| Sale Type | Offer For Sale |
| Total Issue Size | 5,95,61,404 shares (aggregating up to ₹3,395.00 Cr) |
| Employee Discount | ₹50.00 |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 55,90,77,100 shares |
| Share Holding Post Issue | 55,90,77,100 shares |
Anthem Biosciences IPO Lot Size
Investors can bid for a minimum of 26 shares and in multiples thereof.
| Application | Lots | Shares | Amount (₹) |
| Retail (Min) | 1 | 26 | 14,820 |
| Retail (Max) | 13 | 338 | 1,92,660 |
| S-HNI (Min) | 14 | 364 | 2,07,480 |
| S-HNI (Max) | 67 | 1,742 | 9,92,940 |
| B-HNI (Min) | 68 | 1,768 | 10,07,760 |
Company Financials: Anthem Biosciences Ltd.
Anthem Biosciences Ltd.’s revenue increased by 30% and profit after tax (PAT) rose by 23% between the financial year ending March 31, 2025, and March 31, 2024.
| Period Ended | 31 Mar 2025 (₹ Crore) | 31 Mar 2024 (₹ Crore) | 31 Mar 2023 (₹ Crore) |
| Assets | 2,807.58 | 2,398.11 | 2,014.46 |
| Revenue | 1,930.29 | 1,483.07 | 1,133.99 |
| Profit After Tax | 451.26 | 367.31 | 385.19 |
| EBITDA | 683.78 | 519.96 | 446.05 |
| Net Worth | 2,409.86 | 1,924.66 | 1,740.67 |
| Reserves and Surplus | 2,298.05 | 1,815.39 | 1,628.88 |
| Total Borrowing | 108.95 | 232.53 | 125.06 |
Key Performance Indicator (KPI): Anthem Biosciences Ltd.
| KPI | Values |
| ROE | 20.82% |
| ROCE | 26.88% |
| Debt/Equity | 0.05 |
| RoNW | 20.82% |
| PAT Margin | 23.38% |
| EBITDA Margin | 36.81% |
| Price to Book Value | 13.23 |
Objects of the Issue: Purpose of the IPO Funds
The company will not receive any proceeds from the Offer (the “Offer Proceeds”), and all the Offer Proceeds will be received by the Selling Shareholders after deduction of Offer related expenses and relevant taxes thereon, to be borne by the respective Selling Shareholders.
Anthem Biosciences IPO GMP:
The Grey Market Premium (GMP) for Anthem Biosciences IPO is currently ₹97, representing 17.02% over the issue price.
Conclusion and Investor Outlook
Anthem Biosciences Ltd. represents an opportunity in the CRDMO space, driven by innovation and a global client base. While the Shariah compliance status is currently pending, investors should carefully review the company’s strong financials and market position.
Ready to start your investment journey?
Opening a trading account is your first step. Consider these platforms:
- Zerodha: Open your account with Zerodha: https://zerodha.com/?c=NGT561&s=CONSOLE
- Angel One: Download the Angel One app: https://angel-one.onelink.me/Wjgr/92znd9xl
For more detailed information, and company analyses, visit our resources:
- Our Website: https://www.islamicstock.in/
- Our Blog: https://blog.islamicstock.in/
You can also download our application, IslamicStock, for in-depth screenings and much more tailored for you:
- Google Play Store: https://play.google.com/store/apps/details?id=com.halal.stocks&hl=en_IN
- Apple App Store: https://apps.apple.com/in/app/islamicstock-screener-india/id1627541365
SEBI Disclaimer: Investment in securities markets are subject to market risks, read all the related documents carefully before investing. The information provided in this article is for educational and informational purposes only and does not constitute financial advice. Investors should consult with qualified financial professionals before making any investment decisions.